Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06199037
What this trial is testing

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 46
Early research (Phase 1)Ended earlyNCT03483077
What this trial is testing

This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.

Who this might be right for
Healthy
Boehringer Ingelheim 48
Early research (Phase 1)Not Yet RecruitingNCT07717775
What this trial is testing

Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults

Who this might be right for
Gastritis
Addpharma Inc. 30
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Testing effectiveness (Phase 2)Study completedNCT05228470
What this trial is testing

Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Who this might be right for
ElranatamabMyelomaMultiple Myeloma+8 more
Pfizer 39
Testing effectiveness (Phase 2)Study completedNCT01474083
What this trial is testing

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
vTv Therapeutics 248
Early research (Phase 1)Study completedNCT01308541
What this trial is testing

Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Who this might be right for
Monitored Anesthesia Care
Eisai Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT02898753
What this trial is testing

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease
Valerion Therapeutics, LLC 12
Early research (Phase 1)WithdrawnNCT00635245
What this trial is testing

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Pfizer
Early research (Phase 1)Study completedNCT03990519
What this trial is testing

A Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)Ended earlyNCT06365437
What this trial is testing

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 33
Early research (Phase 1)Ended earlyNCT03140072
What this trial is testing

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Who this might be right for
Asthma
AstraZeneca 34
Testing effectiveness (Phase 2)Ended earlyNCT05580770
What this trial is testing

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266
What this trial is testing

Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT02130531
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Kubota Vision Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT00381602
What this trial is testing

A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

Who this might be right for
End Stage Renal Disease
QLT Inc. 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Early research (Phase 1)Study completedNCT05966324
What this trial is testing

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Who this might be right for
Hypertension
AstraZeneca 41
Next Page